Amarin Corp Plc (AMRN)

[Whalatane]

Re your view ..

Then even if the Generics want to sell V off label (for the CVD risk) the drug plans will require all scripts for V to be Tier 4 (up to $350/month) for patients.

If drug plans require V to be Tier 4 ( up to $350 a month ) for the CVD indication ...how does that help AMRN. Even with a $150 coupon ..net cost to consumer for V being $200 a month ...how much do U think they're going to sell .
Not much IMHO

By the way ...expect you are following updates from Japan ...since your previous view was some how they won't be affected much by COVID19

Kiwi